Does personalizing your TRT dose actually improve outcomes?

What did @stevenfnp83 actually say?

The creator's core argument is that handing every patient "same dose, same protocol, no context" is a problem, not a solution. He uses 250 mg of testosterone cypionate weekly as the example of what lazy clinic medicine looks like, and argues that without matching dose to individual labs, sleep, and metabolism, you're not optimizing anything. He closes by pitching one-on-one coaching calls, and is careful to note he isn't prescribing or diagnosing.

That framing matters. He's not saying 250 mg is always wrong. He's saying any fixed dose applied without individual context is the wrong approach. Those are two different claims, and the second one is considerably more defensible than the first. He also flags specific downstream effects: elevated hematocrit, worsened sleep, estrogen dysregulation, and an energy crash after an initial boost. Those are specific, testable claims worth examining on their own.

Does the science back this up?

Mostly, yes. The individual variability argument is well-supported, and the side effects he lists are documented. Where things get murkier is his implicit suggestion that 250 mg is categorically a supraphysiologic or problematic dose for all men, which isn't quite right.

A 2018 study by Bhasin et al. in the New England Journal of Medicine confirmed that testosterone dose-response relationships vary substantially between individuals, with factors like baseline testosterone, SHBG levels, and body composition all influencing how a given dose lands. Similarly, research published by Shores et al. (2020, Journal of Clinical Endocrinology and Metabolism) showed that men on identical TRT protocols reached widely divergent serum testosterone levels, reinforcing the case for lab-based titration.

On hematocrit: the evidence is solid. Testosterone therapy is associated with erythrocytosis in a dose-dependent fashion. Bachman et al. (2010, Journal of Clinical Endocrinology and Metabolism) found hematocrit elevation was one of the most consistent adverse effects across TRT studies. Sleep disruption and worsened sleep apnea are also documented, particularly at higher doses. So his side effect list is not invented.

What did they get wrong, or right?

He got the variability argument right. A one-size protocol in TRT is a real clinical problem, and the research backs him up. The framing around hematocrit, estrogen, and sleep as consequences of dose mismatch is legitimate, not invented for content.

Where he's imprecise: 250 mg per week sits at the higher end of typical TRT dosing, but isn't automatically supraphysiologic for every man. Some guidelines, including the Endocrine Society's 2018 clinical practice guidelines, use weekly injection protocols in broadly similar ranges for hypogonadal patients. The dose is context-dependent, as he argues, but his framing implies 250 mg is a red flag by default. That's a bit too clean.

The coaching pitch deserves scrutiny too. He's careful with his language, "I'm not here to prescribe, diagnose, or replace your provider," but offering guidance on which labs matter and how to interpret them exists in a gray zone. Directing patients on how to evaluate lab results is meaningfully close to clinical guidance, regardless of how it's labeled.

What should you actually know?

TRT dosing is genuinely not one-size-fits-all, and anyone telling you otherwise is oversimplifying. But "personalized" doesn't automatically mean better outcomes, it means more variables to monitor. If you're on testosterone therapy or considering it, there are specific things worth tracking regardless of dose.

• Hematocrit and hemoglobin should be checked at baseline and at 3 to 6 months, per Endocrine Society guidelines. Erythrocytosis above a hematocrit of 54 percent is a documented TRT risk.
• Estradiol (E2) monitoring is genuinely relevant. Testosterone aromatizes to estradiol, and both very high and very low estradiol are associated with symptoms. The relationship isn't simple.
• Sleep apnea screening matters before initiating therapy. Testosterone can worsen existing sleep-disordered breathing, and this is underdiagnosed in men seeking TRT.
• SHBG levels affect how much testosterone is biologically active. Two men with identical total testosterone can have very different free testosterone levels based on SHBG alone.

The creator's broader point, that walking into a clinic without understanding your own labs puts you at a disadvantage, is fair. But "optimization" is a word that gets used to sell a lot of things that are actually just higher doses with more monitoring costs attached. Be skeptical of both the template and the alternative being sold to replace it.